Literature DB >> 25179236

Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology.

Jeppe M Larsen1, Hanieh S Musavian, Tariq M Butt, Camilla Ingvorsen, Anna H Thysen, Susanne Brix.   

Abstract

Recent studies of healthy human airways have revealed colonization by a distinct commensal bacterial microbiota containing Gram-negative Prevotella spp. However, the immunological properties of these bacteria in the respiratory system remain unknown. Here we compare the innate respiratory immune response to three Gram-negative commensal Prevotella strains (Prevotella melaninogenica, Prevotella nanceiensis and Prevotella salivae) and three Gram-negative pathogenic Proteobacteria known to colonize lungs of patients with chronic obstructive pulmonary disease (COPD) and asthma (Haemophilus influenzae B, non-typeable Haemophilus influenzae and Moraxella catarrhalis). The commensal Prevotella spp. and pathogenic Proteobacteria were found to exhibit intrinsic differences in innate inflammatory capacities on murine lung cells in vitro. In vivo in mice, non-typeable H. influenzae induced severe Toll-like receptor 2 (TLR2)-independent COPD-like inflammation characterized by predominant airway neutrophilia, expression of a neutrophilic cytokine/chemokine profile in lung tissue, and lung immunopathology. In comparison, P. nanceiensis induced a diminished neutrophilic airway inflammation and no detectable lung pathology. Interestingly, the inflammatory airway response to the Gram-negative bacteria P. nanceiensis was completely TLR2-dependent. These findings demonstrate weak inflammatory properties of Gram-negative airway commensal Prevotella spp. that may make colonization by these bacteria tolerable by the respiratory immune system.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  asthma; chronic obstructive pulmonary disease; lung immunopathology; microbiota; respiratory inflammation

Mesh:

Substances:

Year:  2015        PMID: 25179236      PMCID: PMC4298427          DOI: 10.1111/imm.12376

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  55 in total

1.  Risk factors for lower airway bacterial colonization in chronic bronchitis.

Authors:  E Monsó; A Rosell; G Bonet; J Manterola; P J Cardona; J Ruiz; J Morera
Journal:  Eur Respir J       Date:  1999-02       Impact factor: 16.671

Review 2.  Pathophysiology of exacerbations of chronic obstructive pulmonary disease.

Authors:  Alberto Papi; Fabrizio Luppi; Francesca Franco; Leonardo M Fabbri
Journal:  Proc Am Thorac Soc       Date:  2006-05

Review 3.  Structure of bacterial lipopolysaccharides.

Authors:  Martine Caroff; Doris Karibian
Journal:  Carbohydr Res       Date:  2003-11-14       Impact factor: 2.104

Review 4.  Role of the gut microbiota in immunity and inflammatory disease.

Authors:  Nobuhiko Kamada; Sang-Uk Seo; Grace Y Chen; Gabriel Núñez
Journal:  Nat Rev Immunol       Date:  2013-05       Impact factor: 53.106

Review 5.  Anaerobic infections: update on treatment considerations.

Authors:  Elisabeth Nagy
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

6.  Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lungs.

Authors:  G J Gaschler; C C J Zavitz; C M T Bauer; M R Stämpfli
Journal:  Eur Respir J       Date:  2010-04-22       Impact factor: 16.671

7.  Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study.

Authors:  Hans Bisgaard; Mette Northman Hermansen; Klaus Bønnelykke; Jakob Stokholm; Florent Baty; Nanna Lassen Skytt; Julia Aniscenko; Tatiana Kebadze; Sebastian L Johnston
Journal:  BMJ       Date:  2010-10-04

Review 8.  Structural and functional analyses of bacterial lipopolysaccharides.

Authors:  Martine Caroff; Doris Karibian; Jean Marc Cavaillon; Nicole Haeffner-Cavaillon
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

9.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.

Authors:  V M Keatings; P D Collins; D M Scott; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

10.  Differential inflammatory response to inhaled lipopolysaccharide targeted either to the airways or the alveoli in man.

Authors:  Winfried Möller; Irene Heimbeck; Thomas P J Hofer; Gülnaz Khadem Saba; Margot Neiswirth; Marion Frankenberger; Löms Ziegler-Heitbrock
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

View more
  54 in total

1.  An integrated respiratory microbial gene catalogue to better understand the microbial aetiology of Mycoplasma pneumoniae pneumonia.

Authors:  Wenkui Dai; Heping Wang; Qian Zhou; Dongfang Li; Xin Feng; Zhenyu Yang; Wenjian Wang; Chuangzhao Qiu; Zhiwei Lu; Ximing Xu; Mengxuan Lyu; Gan Xie; Yinhu Li; Yanmin Bao; Yanhong Liu; Kunling Shen; Kaihu Yao; Xikang Feng; Yonghong Yang; Ke Zhou; Shuaicheng Li; Yuejie Zheng
Journal:  Gigascience       Date:  2019-08-01       Impact factor: 6.524

Review 2.  Lungs, microbes and the developing neonate.

Authors:  Barbara B Warner; Aaron Hamvas
Journal:  Neonatology       Date:  2015-06-05       Impact factor: 4.035

3.  Endotoxin predictors and associated respiratory outcomes differ with climate regions in the U.S.

Authors:  Angelico Mendy; Jesse Wilkerson; Pӓivi M Salo; Richard D Cohn; Darryl C Zeldin; Peter S Thorne
Journal:  Environ Int       Date:  2017-12-23       Impact factor: 9.621

4.  Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study.

Authors:  Marianne S Muhlebach; Joseph E Hatch; Gisli G Einarsson; Stef J McGrath; Deirdre F Gilipin; Gillian Lavelle; Bojana Mirkovic; Michelle A Murray; Paul McNally; Nathan Gotman; Sonia Davis Thomas; Matthew C Wolfgang; Peter H Gilligan; Noel G McElvaney; J Stuart Elborn; Richard C Boucher; Michael M Tunney
Journal:  Eur Respir J       Date:  2018-07-11       Impact factor: 16.671

5.  Nasal Airway Microbiota Profile and Severe Bronchiolitis in Infants: A Case-control Study.

Authors:  Kohei Hasegawa; Rachel W Linnemann; Jonathan M Mansbach; Nadim J Ajami; Janice A Espinola; Joseph F Petrosino; Pedro A Piedra; Michelle D Stevenson; Ashley F Sullivan; Amy D Thompson; Carlos A Camargo
Journal:  Pediatr Infect Dis J       Date:  2017-11       Impact factor: 2.129

6.  Respiratory infection: insights from Assembly 10 of the European Respiratory Society 2017 Annual Congress.

Authors:  Alberto L Garcia-Basteiro; Ernie Wong; Pouline M Van Oort; Catia Cilloniz; Giovanni Battista Migliori; Aran Singanayagam
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 7.  Emerging pathogenic links between microbiota and the gut-lung axis.

Authors:  Kurtis F Budden; Shaan L Gellatly; David L A Wood; Matthew A Cooper; Mark Morrison; Philip Hugenholtz; Philip M Hansbro
Journal:  Nat Rev Microbiol       Date:  2016-10-03       Impact factor: 60.633

Review 8.  The role of the local microbial ecosystem in respiratory health and disease.

Authors:  Wouter A A de Steenhuijsen Piters; Elisabeth A M Sanders; Debby Bogaert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-08-19       Impact factor: 6.237

9.  Endotoxin Exposure: Predictors and Prevalence of Associated Asthma Outcomes in the United States.

Authors:  Peter S Thorne; Angelico Mendy; Nervana Metwali; Päivi Salo; Caroll Co; Renee Jaramillo; Kathryn M Rose; Darryl C Zeldin
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

Review 10.  A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs.

Authors:  Brittan S Scales; Robert P Dickson; Gary B Huffnagle
Journal:  J Leukoc Biol       Date:  2016-06-30       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.